Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ODT

Odonate Therapeutics (ODT) Stock Price, News & Analysis

Odonate Therapeutics logo

About Odonate Therapeutics Stock (NASDAQ:ODT)

Key Stats

Today's Range
N/A
50-Day Range
$1.03
$1.55
52-Week Range
N/A
Volume
87,682 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ODT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Odonate Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ODT Stock News Headlines

Odonate Inc ODTC
ProQR Therapeutics NV (PRQR)
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
ODTC Odonate Therapeutics, Inc.
See More Headlines

ODT Stock Analysis - Frequently Asked Questions

Odonate Therapeutics, Inc. (NASDAQ:ODT) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.33.

Odonate Therapeutics (ODT) raised $150 million in an initial public offering (IPO) on Thursday, December 7th 2017. The company issued 5,900,000 shares at $24.00-$27.00 per share. Goldman Sachs and Jefferies acted as the underwriters for the IPO and Cowen was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Odonate Therapeutics investors own include Intel (INTC), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Energy Transfer (ET), Pfizer (PFE), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/10/2021
Today
10/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ODT
CIK
1717452
Fax
N/A
Employees
145
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
28,530,000
Free Float
14,578,000
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ODT) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners